223 related articles for article (PubMed ID: 22766083)
1. Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study.
Khanna S; Aronson SL; Kammer PP; Baddour LM; Pardi DS
Mayo Clin Proc; 2012 Jul; 87(7):636-42. PubMed ID: 22766083
[TBL] [Abstract][Full Text] [Related]
2. Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.
Tariq R; Singh S; Gupta A; Pardi DS; Khanna S
JAMA Intern Med; 2017 Jun; 177(6):784-791. PubMed ID: 28346595
[TBL] [Abstract][Full Text] [Related]
3. Clinical factors associated with development of severe-complicated Clostridium difficile infection.
Shivashankar R; Khanna S; Kammer PP; Harmsen WS; Zinsmeister AR; Baddour LM; Pardi DS
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1466-71. PubMed ID: 23702192
[TBL] [Abstract][Full Text] [Related]
4. Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study.
Freedberg DE; Lamousé-Smith ES; Lightdale JR; Jin Z; Yang YX; Abrams JA
Clin Infect Dis; 2015 Sep; 61(6):912-7. PubMed ID: 26060292
[TBL] [Abstract][Full Text] [Related]
5. Outcomes in community-acquired Clostridium difficile infection.
Khanna S; Pardi DS; Aronson SL; Kammer PP; Baddour LM
Aliment Pharmacol Ther; 2012 Mar; 35(5):613-8. PubMed ID: 22229532
[TBL] [Abstract][Full Text] [Related]
6. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
[TBL] [Abstract][Full Text] [Related]
7. Exposure to Gastric Acid-Suppression Therapy Is Associated With Health Care- and Community-Associated Clostridium difficile Infection in Children.
Jimenez J; Drees M; Loveridge-Lenza B; Eppes S; delRosario F
J Pediatr Gastroenterol Nutr; 2015 Aug; 61(2):208-11. PubMed ID: 25806678
[TBL] [Abstract][Full Text] [Related]
8. Association of Clostridium difficile infections with acid suppression medications in children.
Nylund CM; Eide M; Gorman GH
J Pediatr; 2014 Nov; 165(5):979-84.e1. PubMed ID: 25112692
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.
Chitnis AS; Holzbauer SM; Belflower RM; Winston LG; Bamberg WM; Lyons C; Farley MM; Dumyati GK; Wilson LE; Beldavs ZG; Dunn JR; Gould LH; MacCannell DR; Gerding DN; McDonald LC; Lessa FC
JAMA Intern Med; 2013 Jul; 173(14):1359-67. PubMed ID: 23780507
[TBL] [Abstract][Full Text] [Related]
10. The epidemiology of community-acquired Clostridium difficile infection: a population-based study.
Khanna S; Pardi DS; Aronson SL; Kammer PP; Orenstein R; St Sauver JL; Harmsen WS; Zinsmeister AR
Am J Gastroenterol; 2012 Jan; 107(1):89-95. PubMed ID: 22108454
[TBL] [Abstract][Full Text] [Related]
11. Complicated Clostridium difficile colitis in children with cystic fibrosis: association with gastric acid suppression?
Com G; Cetin N; O'Brien CE
J Cyst Fibros; 2014 Jan; 13(1):37-42. PubMed ID: 23993432
[TBL] [Abstract][Full Text] [Related]
12. Acid suppression therapy does not predispose to Clostridium difficile infection: the case of the potential bias.
Novack L; Kogan S; Gimpelevich L; Howell M; Borer A; Kelly CP; Leffler DA; Novack V
PLoS One; 2014; 9(10):e110790. PubMed ID: 25343667
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
Freedberg DE; Salmasian H; Friedman C; Abrams JA
Am J Gastroenterol; 2013 Nov; 108(11):1794-801. PubMed ID: 24060760
[TBL] [Abstract][Full Text] [Related]
14. Acid-Suppressing Agents and Risk for Clostridium difficile Infection in Pediatric Patients.
Brown KE; Knoderer CA; Nichols KR; Crumby AS
Clin Pediatr (Phila); 2015 Oct; 54(11):1102-6. PubMed ID: 25644650
[TBL] [Abstract][Full Text] [Related]
15. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.
Kwok CS; Arthur AK; Anibueze CI; Singh S; Cavallazzi R; Loke YK
Am J Gastroenterol; 2012 Jul; 107(7):1011-9. PubMed ID: 22525304
[TBL] [Abstract][Full Text] [Related]
16. Does PPI therapy predispose to Clostridium difficile infection?
Pant C; Madonia P; Minocha A
Nat Rev Gastroenterol Hepatol; 2009 Sep; 6(9):555-7. PubMed ID: 19713988
[TBL] [Abstract][Full Text] [Related]
17. Acid Suppression Medications During Hospitalization as a Risk Factor for Recurrence of Clostridioides difficile Infection: Systematic Review and Meta-analysis.
Mehta P; Nahass RG; Brunetti L
Clin Infect Dis; 2021 Jul; 73(1):e62-e68. PubMed ID: 32386313
[TBL] [Abstract][Full Text] [Related]
18. The epidemiology of Clostridium difficile infection in children: a population-based study.
Khanna S; Baddour LM; Huskins WC; Kammer PP; Faubion WA; Zinsmeister AR; Harmsen WS; Pardi DS
Clin Infect Dis; 2013 May; 56(10):1401-6. PubMed ID: 23408679
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile infection in the community: are proton pump inhibitors to blame?
Freedberg DE; Abrams JA
World J Gastroenterol; 2013 Oct; 19(40):6710-3. PubMed ID: 24187445
[TBL] [Abstract][Full Text] [Related]
20. Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study.
Kuntz JL; Chrischilles EA; Pendergast JF; Herwaldt LA; Polgreen PM
BMC Infect Dis; 2011 Jul; 11():194. PubMed ID: 21762504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
